Page last updated: 2024-10-16

5-hydroxytryptophan and Ophthalmoplegia, Progressive Supranuclear

5-hydroxytryptophan has been researched along with Ophthalmoplegia, Progressive Supranuclear in 2 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yukitake, M1
Takashima, Y1
Kurohara, K1
Matsui, M1
Kuroda, Y1
Kompoliti, K1
Goetz, CG1
Litvan, I1
Jellinger, K1
Verny, M1

Other Studies

2 other studies available for 5-hydroxytryptophan and Ophthalmoplegia, Progressive Supranuclear

ArticleYear
[Improvement of ophthalmoplegia by 5-hydroxytryptophan in two cases of progressive supranuclear palsy].
    Rinsho shinkeigaku = Clinical neurology, 1996, Volume: 36, Issue:7

    Topics: 5-Hydroxytryptophan; Aged; Female; Humans; Male; Ophthalmoplegia; Supranuclear Palsy, Progressive

1996
Pharmacological therapy in progressive supranuclear palsy.
    Archives of neurology, 1998, Volume: 55, Issue:8

    Topics: 5-Hydroxytryptophan; Aged; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Autopsy; Choliner

1998